Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
GLUT4, Glucose transporter type 4
The combination of GLP-1 and GIP activation, first demonstrated with tirzepatide (Mounjaro/Zepbound), showed superior weight loss compared to GLP-1 alone
Not for human or veterinary consumption, diagnostic, or therapeutic use
2ac, Supplementary Materials & Methods Table S2)
256 Mutations in Fbw7, observed in breast and ovarian cancers, lead to cyclin E accumulation, premature S-phase entry, chromosomal instability, and tumor formation
US$ 23.59
US$ 27.22
US$ 23.27
US$ 21.92
US$ 25.61
